2019
DOI: 10.1016/j.pan.2019.01.010
|View full text |Cite
|
Sign up to set email alerts
|

Activation of IGF/IGF-IR signaling pathway fails to induce epithelial-mesenchymal transition in pancreatic cancer cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
8
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(9 citation statements)
references
References 24 publications
1
8
0
Order By: Relevance
“…The Group ABGI is the most expressed, whereas the Group CDE, which is composed by potential coding transcript variants, is almost undetectable in most cell lines ( Figure 3A). Interestingly, in pancreatic tumors the highest expression of HMGA2-AS1 transcripts was found in PANC1 cell line, which is considered more aggressive than BX-PC3 (43)(44)(45). Similarly, we observed a higher expression of HMGA2-AS1 transcripts in prostatic cancer cell line PC3 with respect to DU145 cell line ( Figure 3A).…”
Section: Hmga2-as1 Transcript Variants Are Expressed In Cancer Cell Lsupporting
confidence: 56%
“…The Group ABGI is the most expressed, whereas the Group CDE, which is composed by potential coding transcript variants, is almost undetectable in most cell lines ( Figure 3A). Interestingly, in pancreatic tumors the highest expression of HMGA2-AS1 transcripts was found in PANC1 cell line, which is considered more aggressive than BX-PC3 (43)(44)(45). Similarly, we observed a higher expression of HMGA2-AS1 transcripts in prostatic cancer cell line PC3 with respect to DU145 cell line ( Figure 3A).…”
Section: Hmga2-as1 Transcript Variants Are Expressed In Cancer Cell Lsupporting
confidence: 56%
“…We first analyzed the expression of Arid5a in commercially available human pancreatic cancer cell lines retaining epithelial and quasi-mesenchymal (QM) characteristics (27,28).…”
Section: Arid5a Promotes Immune Evasion By Pancreatic Cancermentioning
confidence: 99%
“…The upregulated expression of IGF-1 also predicted a poor clinical outcome in patients with PC. Moreover, the IGF-1 receptor (IGF-1R) was revealed to have tyrosine kinase activity (30). Upon IGF-1R binding with IGF-1, the receptor is activated and increases the phosphorylation levels of AKT and MEK proteins, leading to the activation of intracellular signaling pathways, such as the PI3K/Akt/mTOR pathway and RAS/RAF/MEK/ERK signaling pathway (31).…”
Section: Discussionmentioning
confidence: 99%